Clin Exp Pharmacol Physiol. 2018 Aug;45(8):885. doi: 10.1111/1440-1681.12948.
The above article, published online on 17 April 2018 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the authors, the journal Editor in Chief, Prof. Jun-Ping Liu, and John Wiley & Sons, Ltd. The authors have withdrawn the paper due to the lack of reproducibility of some of the findings reported in the paper during the consequent experimental work (in particular, the numeric data related to the levels of proteins involved into or responsive to induction of NADPH oxidase pathway). Although these discrepancies do not affect the major conclusions of the paper, the possible presence of incorrect experimental data requires serious revision of the manuscript and thus necessitates the withdrawal of the article.
Wang Q, Sui X, Chen R, et al. Anti-fibrotic actions of Ghrelin by inhibition of the NADPH oxidase-ROS signalling pathway. Clin Exp Pharmacol Physiol 2018;00:1-14. https://doi.org/10.1111/1440-1681.12948.
上述文章于2018年4月17日在线发表于威利在线图书馆(wileyonlinelibrary.com),经作者、期刊主编刘俊平教授与约翰·威利父子有限公司协商一致后撤回。作者撤回该论文的原因是,在随后的实验工作中,论文所报告的部分研究结果缺乏可重复性(特别是与参与或响应NADPH氧化酶途径诱导的蛋白质水平相关的数值数据)。尽管这些差异不影响论文的主要结论,但可能存在的不正确实验数据需要对手稿进行认真修订,因此有必要撤回该文章。
Wang Q, Sui X, Chen R, 等。Ghrelin通过抑制NADPH氧化酶-ROS信号通路发挥抗纤维化作用。临床与实验药理学与生理学2018;00:1 - 14。https://doi.org/10.1111/1440-1681.12948 。